BIO and Pennsylvania Bio commended Pennsylvania Senate Public Health and Welfare Committee for its approval of Senate Bill 405, which would require pharmacist to notify patient, and within 72 hours, the patient's physician of any biologic product substitution. Bill seeks to properly preserve patient access to accurate prescription information, maintains incentives for innovation, and promotes competitive market for biologic therapies.
This story is related to the following:Trade Associations